The Enterprise convened a day-long think tank of experts to address challenges associated with developing a durable, protective HIV vaccine and to identify areas of research that should be prioritized.
The Enterprise and partners will release ‘From Bench to Clinic – An Researchers Guide to Move Vaccine Candidates into Trials’ in September. The web-based guide will acquaint researchers, funders and...
The Global HIV Vaccine Enterprise
is accelerating the development of preventive HIV vaccines through mutual coordination, collaboration, knowledge sharing and recruitment of new resources and funders to the field.